New York, NY — April, 28 2026
As the orthodontic community convenes for the AAO 2026 in Orlando, Biolux Technology will showcase OrthoPulse lite—the next evolution in near-infrared light for orthodontics, positioned to move photobiomodulation (PBM) from innovation to standard of care.
Already gaining traction across leading U.S. practices, OrthoPulse is redefining treatment efficiency and clinical predictability. As the only FDA-cleared near-infrared light device in orthodontics, OrthoPulse utilizes proprietary 850 nm technology to biologically support tooth movement, bridging the gap between digital treatment planning and real-world outcomes.
A Scalable Standard for Modern Orthodontics
With OrthoPulse lite, Biolux introduces a streamlined, more accessible platform, without compromising clinical integrity or performance. The system integrates seamlessly across aligner and fixed appliance workflows, enabling practices to standardize PBM across all patient types.
Consistent clinical and real-world outcomes include:
Accelerated treatment progression
Reduced refinements and finishing aligners
Enhanced patient comfort and compliance
Clinical Leadership Driving Adoption
OrthoPulse has fundamentally changed how we deliver care. This isn’t about speed alone—it’s about control and predictability. When you can consistently move teeth as planned, you elevate outcomes across every case. At this point, it’s not optional in our practice—it’s standard of care.
— Dr. Paola Leone, co-owner at L&V Orthodontics, Seattle, WA
Experience OrthoPulse lite at AAO 2026
Biolux invites attendees to experience OrthoPulse lite live at Booth #1268 during AAO 2026. Live demonstrations, clinical insights, and real-world case data will highlight how practices can scale adoption and drive more predictable outcomes.
Exclusive AAO Offering
To support accelerated adoption, Biolux will introduce a limited-time AAO promotion, enabling practices to implement OrthoPulse lite across their patient base with compelling economics.
About OrthoPulse
OrthoPulse is the pioneer in near-infrared photobiomodulation therapy for orthodontics and the only FDA-cleared device indicated as an adjunct to orthodontic treatment. With a growing global presence and regulatory approvals across major international markets, OrthoPulse supports improved efficiency, enhanced comfort, and predictable outcomes for both aligner and fixed appliance workflows.
Learn more at: www.orthopulse.com
Media Contact: Michael Hendricks
Chief Revenue Officer, Biolux Technology USA LLC